Good Simulation Practice

In close collaboration with the Avicenna Alliance, In Silico World community of practice hosts the consensus process to develop the so-called Good Simulation Practice.

The idea is to develop eventually something equivalent to the Good Clinical Practice defined by the International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.

A first step in this consensus process is the collection of regulatory documents published worldwide that might be relevant for this consensus process.

You can contribute by joining the GSP Task Force established by the Avicenna Alliance in collaboration with the Medical Device Innovation Consortium and the Food and Drugs Administration

The Avicenna Alliance has created a GSP Task Force within its Policy Development Working Group with the scope to drive this consensus process, develop this collection of draft and supporting documents, and then provide a sounding board to future standardisation efforts as part of a global GSP Initiative.

The GSP Initiative is a grass-root initiative, open to individuals and organisations.

> Discover more about the GSP Task Force

A first step toward the compilation of the GSP is to collect all regulatory documents of the various authorities around the world that are related to this topic.

> Browse GSP document collection

Are you an expert on in silico and want to join the conversation on GSP?

> Join the GSP channel on the Community

Go to Scalability →